Durlobactam
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Durlobactam is a beta-lactamase inhibitor used in combination with sulbactam to treat susceptible strains of bacteria in the genus Acinetobacter It is an analog of avibactam. The combination therapy sulbactam/durlobactam was approved for medical use in the United States in May 2023.
Durlobactam is a beta-lactamase inhibitor used in combination with sulbactam to treat susceptible strains of bacteria in the genus Acinetobacter It is an analog of avibactam. The combination therapy sulbactam/durlobactam was approved for medical use in the United States in May 2023.
See also
Diazabicyclooctane β-lactamase inhibitor ETX0462
Text derived from https://en.wikipedia.org/w/index.php?oldid=1363446725 under CC BY-SA 4.0; modifications have been made.